Active Wnt3A-V5 Citations (5)

Originally described in: Disulfide Bond Requirements for Active Wnt Ligands.
MacDonald BT, Hien A, Zhang X, Iranloye O, Virshup DM, Waterman ML, He X J Biol Chem. 2014 May 19. pii: jbc.M114.575027. PubMed Journal

---

Articles Citing Active Wnt3A-V5

Articles
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis. Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW. Cancer Res. 2017 Mar 15;77(6):1331-1344. doi: 10.1158/0008-5472.CAN-16-0497. Epub 2017 Jan 20. PubMed
ERAD-dependent control of the Wnt secretory factor Evi. Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, Christianson JC, Boutros M. EMBO J. 2018 Feb 15;37(4). pii: embj.201797311. doi: 10.15252/embj.201797311. Epub 2018 Jan 29. PubMed
JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling. Adhikari A, Davie J. Epigenetics Chromatin. 2018 Aug 17;11(1):46. doi: 10.1186/s13072-018-0217-x. PubMed
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models. Gherardini L, Inzalaco G, Imperatore F, D'Aurizio R, Franci L, Miragliotta V, Boccuto A, Calandro P, Andreini M, Tarditi A, Chiariello M. Cancers (Basel). 2021 Sep 27;13(19). pii: cancers13194830. doi: 10.3390/cancers13194830. PubMed
Atypical TGF-beta signaling controls neuronal guidance in Caenorhabditis elegans. Baltaci O, Pedersen ME, Sherry T, Handley A, Snieckute G, Cao W, Haas M, Archer S, Pocock R. iScience. 2022 Jan 18;25(2):103791. doi: 10.1016/j.isci.2022.103791. eCollection 2022 Feb 18. PubMed

If you have published an article using this material, please email us at to have your article added to this page.